Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Europe’s neurologists unfamiliar with emerging Alzheimer’s drugs

November 17, 2010
Research and Development, Sales and Marketing Alzheimer's, Aricept, Decision Resources, Europe, Pfizer

A survey of neurologists in Europe has shown only a minority are aware of late stage drugs being developed to …

News
quintiles_john_procter

Pfizer’s John Proctor moves to Quintiles

November 15, 2010
Sales and Marketing John Proctor, Pfizer, Quintiles, UK, appointment, sales and marketing

Quintiles has appointed the former head of Pfizer Health Solutions to lead its own Health Management Solutions (HMS) business. As …

Appointment
Blog footer

Digital Pharma: Pfizer and Boehringer’s online COPD awareness

November 12, 2010
Medical Communications Boehringer Ingelheim, COPD, Digital Pharma blog, Managing COPD, NICE, Pfizer, Spiriva, chronic obstructive pulmonary disease

Pfizer and Boehringer Ingelheim have launched an online campaign to publicise the latest NICE guidelines on COPD to healthcare professionals …

News

Pfizer enters drug repositioning collaboration with Biovista

November 11, 2010
Research and Development Biovista, FDA, Neurontin, Pfizer, Pfizer Indications Discovery Unit, drug repositioning, viagra

Pfizer has signed a pilot research agreement with drug repositioning specialist Biovista. The aim of the collaboration is to identify …

News
Pfizer and Boehringer's COPD campaign website

Pfizer and Boehringer pilot COPD campaign

November 9, 2010
Medical Communications Boehringer Ingelheim, COPD, Pfizer, Salford, chronic bronchitis, chronic obstructive pulmonary disease, emphysema

Pfizer and Boehringer Ingelheim have mobilised a soap opera star, painted rugby players and a special ‘breathing bus’ for a …

News

Late stage trial boost for Pfizer’s arthritis drug tasocitinib

November 8, 2010
JAK inhibitors, Pfizer, arthritis, tasocitinib

Pfizer’s rheumatoid arthritis treatment tasocitinib has met its two of its three primary endpoints in a phase III trial. Primary …

News

Pfizer Q3 profits hit hard

November 3, 2010
Sales and Marketing Liptior sales, Pfizer, Pfzier Q3 results, Wyeth

The integration of Wyeth into Pfizer continues to drive its revenue growth, but at a cost – charges from the …

News

Pfizer pulls more Lipitor over odour problem

November 2, 2010
Manufacturing and Production Lipitor, Lipitor recall, Pfizer, manufacturing compliance, recalls

Pfizer has widened its Lipitor recall after yet another incident in which consumers reported a musty smell emanating from bottles …

News

Pfizer to seek US approval for crizotinib next year

November 1, 2010
Research and Development, Sales and Marketing FDA submission, NSCLC, Pfizer, crizotinib, lung cancer, non-small cell lung cancer

Pfizer will submit its lung cancer candidate crizotinib to the FDA for US approval in the first half of next …

News

NICE refuses cancer drugs Arzerra, Torisel and Levact

October 27, 2010
Sales and Marketing Arzerra, GSK, NICE, Napp Pharmaceuticals, Pfizer, Torisel, Treanda, cancer drugs

NICE has refused to recommend a trio of cancer drugs for NHS use – but in two cases says this …

News

Two thirds of pharma companies face ‘strategic crisis’

October 25, 2010
Research and Development, Sales and Marketing Novartis, Pfizer, Roland Berger, generics, pharma research, pharma sales

The pharma industry is moving away from traditional in-house innovation and toward a more diversified business model, but will encounter …

News
Blog footer

Digital Pharma: Pfizer, Enbrel and UK Google Adwords

October 22, 2010
Medical Communications ABPI Code of Practice, Digital Pharma blog, Enbrel, Google Adwards, PMCPA, Pfizer, pharma SEO

Pfizer is using Google Adwords in the UK to promote an online eCongress for healthcare professionals interested in its arthritis …

News

Pfizer recalls Lipitor tablets because of ‘musty’ smell

October 22, 2010
Manufacturing and Production Lipitor, Pfizer, pharma recalls, product recalls

Pfizer has recalled 191,000 bottles of its cholesterol drug Lipitor in the US after customers complained of an unusual, musty …

News

Pfizer extends portfolio with Brazilian generics deal

October 21, 2010
Brazil, IMS Health, Pfizer, em, emerging pharma marketings

Pfizer is partnering with leading Brazilian generics firm Laboratorio Teuto Brasileiro to develop and commercialise a number of generic products …

News

Apixaban trial for ACS abandoned

October 20, 2010
Sales and Marketing ACS, BMS, Pfizer, apixaban

  Pfizer and Bristol-Myers Squibb have halted a trial of their heart drug apixaban after signs of increased risk of …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026